Evidence map›Paper›PMID 31613026›Full record

ArticleJournal of orthopaedic research : official publication of the Orthopaedic Research Society2020

Generation of Human-Induced Pluripotent Stem Cells From Anterior Cruciate Ligament.

Steven Woods, Nicola Bates, Sara L Dunn, Ferdinand Serracino-Inglott, Tim E Hardingham, Susan J Kimber

Open access · hybridAbstract readEvaluation Study
In one paragraph

Article in Journal of orthopaedic research : official publication of the Orthopaedic Research Society, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
0.9field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 21 citations in OpenAlex.

  1. Review
  2. Progress in preclinical research on induced pluripotent stem cell therapy for acute myocardial infarction.Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences · 2024
    Review
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Steven WoodsDivision of Cell Matrix Biology and Regenerative Medicine, School of Biological Sciences, University of Manchester, Michael Smith Building, Oxford Rd, Manchester, M13 9PT, United Kingdom.ORCID 0000-0001-6873-5722
Nicola BatesDivision of Cell Matrix Biology and Regenerative Medicine, School of Biological Sciences, University of Manchester, Michael Smith Building, Oxford Rd, Manchester, M13 9PT, United Kingdom.
Sara L DunnDivision of Cell-Matrix Biology and Regenerative Medicine, Wellcome Trust Centre for Cell-Matrix Research, Faculty of Biology, Medicine and Health, School of Biological Sciences, University of Manchester, Manchester, United Kingdom.
Ferdinand Serracino-InglottDepartment of Vascular Surgery, Central Manchester NHS Foundation Trust, Manchester, United Kingdom.
Tim E HardinghamDivision of Cell-Matrix Biology and Regenerative Medicine, Wellcome Trust Centre for Cell-Matrix Research, Faculty of Biology, Medicine and Health, School of Biological Sciences, University of Manchester, Manchester, United Kingdom.
Susan J KimberDivision of Cell Matrix Biology and Regenerative Medicine, School of Biological Sciences, University of Manchester, Michael Smith Building, Oxford Rd, Manchester, M13 9PT, United Kingdom.ORCID 0000-0002-0568-6342
Wellcome Centre for Cell-Matrix Research · GBManchester University NHS Foundation Trust · GB

Funding

Arthritis Research UK 20414FP7 Health 602300FP7 Health FP7/2007-2013Medical Research Council MR/S002553/1Versus Arthritis 20414Versus Arthritis 20786
6 · The paper itself

Abstract

Human-induced pluripotent stem cells (hiPSCs) are reprogrammed somatic cells and are an excellent cell source for tissue engineering applications, disease modeling, and for understanding human development. HiPSC lines have now been generated from a diverse range of somatic cell types and have been reported to retain an epigenetic memory of their somatic origin. To date, the reprogramming of a true ligament has not been reported. The aim of this study is to generate iPSCs from human anterior cruciate ligament (ACL) cells. ACL cells from three above-knee amputation donors, with donor matched dermal fibroblasts (DFs) were tested for reprogramming using an existing DF reprogramming protocol. ACL cells were, however, more sensitive than donor matched DF to transforming growth factor-β (TGF-β); displaying marked contraction, increased proliferation and increased TNC and COMP expression in vitro, which hindered reprogramming to iPSCs. Modification of the protocol by scoring the cell monolayer or by removal of TGF-β during ACL reprogramming resulted in emerging colonies being easier to identify and extract, increasing reprogramming efficiency. Following 30 passages in culture, the generated ACL derived iPSCs displayed pluripotency markers, normal karyotype and can successfully differentiate to cells of the three embryonic germ layers. This study illustrates it is possible to generate hiPSCs from ligament and identifies optimized ligament reprogramming conditions. ACL derived iPSCs may provide a promising cell source for ligament and related tissue engineering applications. © 2019 The Authors. Journal of Orthopaedic Research® published by Wiley Periodicals, Inc. on behalf of Orthopaedic Research Society J Orthop Res 38:92-104, 2020.

Indexed as

Cellular Reprogramming TechniquesInduced Pluripotent Stem CellsAnterior Cruciate LigamentHumansanterior cruciate ligamenthuman induced pluripotent stem cellsligament differentiationreprogrammingtissue engineering

Identifiers

PMID31613026
PMCPMC6972590
OpenAlexW2980497968

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.